TargetMol

Fluvastatin sodium

Product Code:
 
TAR-T1487
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T1487-25mg25mg£108.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1487-1mL1 mL * 10 mM (in DMSO)£121.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1487-50mg50mg£123.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1487-100mg100mg£141.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1487-200mg200mg£170.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Fluvastatin sodium, a competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase (HMGCR), is a commonly used cholesterol lowering agent.
CAS:
93957-55-2
Formula:
C24H25FNNaO4
Molecular Weight:
433.455
Pathway:
Autophagy; Cell Cycle/Checkpoint; Apoptosis; Metabolism
Purity:
0.9946
SMILES:
[Na+].CC(C)n1c(C=CC(O)CC(O)CC([O-])=O)c(-c2ccc(F)cc2)c2ccccc12
Target:
Ferroptosis; HMG-CoA Reductase; Autophagy

References

1. Dansette PM, et al. Exp Toxicol Pathol, 2000, 52(2), 145-148. 2. Yamamoto A, et al. J Pharm Pharmacol, 2001, 53(2), 227-232. 3. Imaeda A, et al. Free Radic Res, 2001, 35(6), 789-801. 4. Kugi M, et al. Cardiovasc Drugs Ther, 2002, 16(3), 203-207. 5. Mitani H, et al. Br J Pharmacol, 1996, 119(6), 1269-1275.